Skip to content

Building Biotechnology Scientists Know Science; Businesspeople Know Business. This Book Explains Both. : Biotechnology Business, Regulations, Patents, Law, Policy and Science

Best in textbook rentals since 2012!

ISBN-10: 1934899291

ISBN-13: 9781934899298

Edition: 4th 2014

Authors: Yali Friedman

List price: $74.95
Shipping box This item qualifies for FREE shipping.
Blue ribbon 30 day, 100% satisfaction guarantee!
what's this?
Rush Rewards U
Members Receive:
Carrot Coin icon
XP icon
You have reached 400 XP and carrot coins. That is the daily max!

Description:

Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, policy, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs. This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more…    
Customers also bought

Book details

List price: $74.95
Edition: 4th
Copyright year: 2014
Publisher: ThinkBiotech, LLC
Binding: Paperback
Pages: 388
Size: 7.00" wide x 10.00" long x 0.80" tall
Weight: 1.760
Language: English

Yali Friedman is Chief Knowledge Officer at Washington, DC-based New Economy Strategies and holds a doctorate in biochemistry from the University of Buffalo. He currently guest lectures for the Johns Hopkins MS/MBA program in biotechnology and has been a guest lecturer at the Tepper School of Business and University of Buffalo School of Management, teaching classes on the business of biotechnology. In supporting New Economy Strategies' activities in technology-based economic development, he has published papers on topics such as strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, entrepreneurship in biotechnology, and new…